PTC’s ThingWorx Continues Strong Momentum as Industry-Leading IIoT Platform
PTC (NASDAQ: PTC) is concluding its 2019 fiscal year with the ThingWorx® Industrial Internet of Things (IIoT) platform recognized as the IIoT platform of choice for industrial companies around the world. This continued recognition has been driven by alliance-led milestones, widespread client adoption, and the company’s ongoing investment in ThingWorx and commitment to its customers’ success.
“With ThingWorx, thousands of companies are realizing the promise of a connected enterprise through digital transformation objectives,” said Kathleen Mitford, executive vice president, Products, PTC. “The success of ThingWorx proves the market is moving from acceptance to adoption — and that digitization is now truly achievable.”
As of September 2019, approximately 2,000 global customers are using ThingWorx to connect their products, factories, processes, and people. Customers who have realized early success with ThingWorx and are now expanding the scope and scale of use include BID Group, Carlsberg Group, Celli Group, Flowserve, and Stellar. With ThingWorx, these companies are improving their manufacturing processes, enabling remote monitoring of products, driving connected operations, and much more.
Announced at this year’s LiveWorx® digital transformation event, ThingWorx 8.5 is available today. ThingWorx 8.5 has new capabilities that equip engineers, manufacturers, service professionals, and IT/OT digital transformation teams with world-class, domain-specific functionality, including:
- More Manufacturing Applications – The new ThingWorx Operator Advisor app empowers workforces with a single screen that delivers actionable work instructions contextualized with work orders, machine data, and product configurations, while the ThingWorx Production Advisor app now delivers a greater number of key performance indicators (KPIs) to help monitor real-time operational performance.
- Expanded Analytics Ecosystem – Powerful machine learning functionality within ThingWorx can now be accessed by users of Rockwell Automation’s FactoryTalk Analytics DataFlowML platform for predictive model scoring and data set creation, thus optimizing processes to increase operational efficiencies.
- Improved Asset Hierarchy Configuration – The ThingWorx Asset Advisor app supports flexible segmentation of assets, allowing users to tailor workflows and analytics according to business logic, visibility requirements, authorizations, and permissions.
- Centralized Administrative Portal – ThingWorx Solution Central is a new, centralized, cloud-based portal that allows administrators to discover, deploy, and manage ThingWorx applications across their distributed enterprises from a single location.
- Enhanced Integration with Microsoft Azure and Azure IoT Hub – ThingWorx 8.5 provides a seamless integration experience for ThingWorx customers using Microsoft Azure services via direct access to Azure functionality from ThingWorx applications.
- Expanded Connectivity Deployment Options – The ThingWorx Kepware® Edge solution, part of PTC's Kepware® industrial connectivity technology, enables cross-platform distribution for customers deploying solutions on Linux-based systems and on smaller-footprint IoT edge gateways.
- Modernized User Interface (UI) Tools – ThingWorx 8.5 supports enhanced styling and theming with pre-built UI widgets, helping companies conform to corporate style guides, branding objectives, and web standards.
In addition, Navigate 8.5, also available today, introduces the first Contribute App, which enables a broad range of cross-functional users to fully participate in a digital change management workflow, thus improving the quality of change requests and seamless development through reusable components.
An important component of ThingWorx’s success has been the expansive PTC Partner Network, particularly the company’s strategic alliances with Rockwell Automation and Microsoft, which continue to help bring ThingWorx into new and emerging markets around the world. Most recently, PTC was highlighted at the 2019 Microsoft Partner of the Year Awards as Manufacturing and Resources Partner of the Year, Mixed Reality Partner of the Year, and a finalist for IoT Partner of the Year.
PTC has also been recognized for its advancements in the IIoT platform market and was positioned as a leader in IDC’s recent worldwide research report entitled “IDC MarketScape: Worldwide Industrial IoT Platforms in Manufacturing 2019 Vendor Assessment”. Independent industry analyst firm, Gartner, placed PTC in the "Visionaries” quadrant in its Magic Quadrant for Industrial IoT platforms for its ability to execute in the IIoT market for the second consecutive year. These acknowledgments, and many other industry accolades , validate the strength of the ThingWorx platform and PTC’s commitment to helping its customers succeed in their digital transformations.
- ThingWorx IIoT Solution Platform
- Industry Awards and Recognition
- Video: Three IoT Considerations for Strategy Beyond Service
- Blog: What Are the Top Benefits of IoT in Manufacturing?
- Harvard Business Review: "How Smart, Connected Products are Transforming Competition," authors PTC CEO Jim Heppelmann and Harvard Professor Michael Porter
- Engineering.com: Democratizing Change Review with ThingWorx Navigate Contribute
About PTC (NASDAQ: PTC)
PTC unleashes industrial innovation with award-winning, market-proven solutions that enable companies to differentiate their products and services, improve operational excellence, and increase workforce productivity. With PTC, and its partner ecosystem, manufacturers can capitalize on the promise of today’s new technology to drive digital transformation.
The announcement of any particular selection or implementation of PTC products is not necessarily indicative of the timing of recognition of revenue therefrom or the level of revenue for any particular period.
PTC, ThingWorx, LiveWorx, Kepware, and the PTC logo are trademarks or registered trademarks of PTC Inc. and/or its subsidiaries in the United States and other countries.
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Vertex and Republic of Ireland Expand Long-Term Cystic Fibrosis Medicines Reimbursement Agreement to Include Triple Combination Therapy for All Eligible Patients Ages 12 and Over Once Licensed13.12.2019 21:55:00 EET | Press release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today confirmed that, following recent collaborative discussions, it has negotiated an agreement with the Health Service Executive (HSE) in the Republic of Ireland to expand the existing long-term cystic fibrosis (CF) reimbursement agreement to include the triple combination regimen (elexacaftor, tezacaftor and ivacaftor), which is under review and pending approval by the European Medicines Agency, for all eligible patients ages 12 and older in line with the potential future licensed indication. This expands the existing agreement which had already included access to current and future Vertex medicines for people in Ireland with CF of any age who: Have one of the specified mutations as included in the KALYDECO® marketing authorization (G551D, G551S, S549R, G1244E, S1251N, G1349D, S1255P, G178R or S549N) or Are homozygous for the F508del mutation or Are heterozygous for the F508del mutation and have a specified mutation (P67L, D579G, D1
CreditLens™ Solution Receives SOC 2 Attestation Report13.12.2019 18:17:00 EET | Press release
Moody’s Analytics announced today that the CreditLens software-as-a-service (SaaS) solution has received an attestation report from the American Institute of Certified Public Accountants (AICPA) System and Organization Controls (SOC 2). The SOC 2 report details the security and availability of customer data in the CreditLens SaaS solution, and denotes its adherence to the AICPA’s security and availability controls standards. Built on the latest cloud-based technology, the CreditLens platform helps businesses digitally transform their commercial credit processes to make faster and better-informed decisions. It facilitates process automation and helps clients improve their efficiency, reduce errors, and streamline workflows. A SOC 2 report ensures that a company’s information security measures are in line with the unique parameters of today’s cloud requirements. The report addresses a service organization's controls that relate to operations and compliance, as outlined by the AICPA's Tru
CHMP Grants Positive Opinion for Expanded Use of Darzalex®▼ (daratumumab) in Combination with Bortezomib, Thalidomide and Dexamethasone (VTd) for Patients with Newly Diagnosed Multiple Myeloma Who Are Transplant Eligible13.12.2019 14:47:00 EET | Press release
The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended broadening the existing marketing authorisation for Darzalex®▼ (daratumumab) to include the use of daratumumab in combination with bortezomib, thalidomide and dexamethasone (VTd) for the treatment of adult patients with newly diagnosed patients with multiple myeloma who are eligible for autologous stem cell transplant (ASCT). The Positive Opinion is supported by data from Part 1 of the Phase 3 CASSIOPEIA (MMY3006) study, published in The Lancet 3 in June 2019, and presented at the 2019 American Society of Clinical Oncology (ASCO) Meeting. Additional information about this study can be found at www.ClinicalTrials.gov (NCT02541383). “Today’s Opinion takes us a step closer to offering the first daratumumab combination regimen to transplant eligible patients, redefining treatment for those people newl
Janssen Receives Positive CHMP Opinion for Expanded Use of Erleada® (apalutamide) for Patients with Metastatic Hormone-Sensitive Prostate Cancer13.12.2019 14:40:00 EET | Press release
The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a Positive Opinion recommending approval for expanding the use of Erleada® (apalutamide) to include the treatment of adult men with metastatic hormone-sensitive prostate cancer (mHSPC) in combination with androgen deprivation therapy (ADT).2 The CHMP’s Positive Opinion will now be reviewed by the European Commission (EC), which has the authority to grant approval for the new use of apalutamide. The Positive Opinion is based on data from the Phase 3 TITAN study, which assessed the addition of apalutamide to ADT – the current standard of care in mHSPC – in a broad range of patients with mHSPC, regardless of disease volume, prior treatment with docetaxel or staging at initial diagnosis. The dual primary endpoints of the study were overall survival (OS) and radiographic progression-free survival (rPFS). Ap
German Player Karl Rupprec Wins 2019 Boyaa Poker Tournament Europe13.12.2019 12:24:00 EET | Press release
On December 8, the sixth edition of the BPT (Boyaa Poker Tournament) came to an end. King's Resort in the Czech Republic celebrated this BPT Europe that enjoyed 600 cumulative participants from 20 countries. In the end, Karl Rupprec, from Germany, won the Main Event Championship. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191213005109/en/ (Photo: Business Wire) Highlights of the BPT Europe 2019 final The BPT Europe 2019 Main Event began on December 8 at 2:00 p.m., Czech Republic time. After 9 hours of Texas Poker, players Ondrej Drozd from the Czech Republic and Karl Rupprec from Germany reached the last heads-up. In the end, Karl Rupprec, who started with half of his opponent's chips, reversed the situation with his two nines, winning the championship. Heads-up Highlights: Karl Rupprec pair 9 and Ondrej Drozd 2, 5. The flop was 2, Q, 9, so Karl Rupprec got three of a kind, and Ondrej Drozd got pair 2. Rupprec pretended
Seoul Semiconductor’s SunLike Series Natural Spectrum LEDs Adopted by Italian Designed Architectural Lighting Brand for Motorized Luminaire with Smart Wireless Controls13.12.2019 12:00:00 EET | Press release
Seoul Semiconductor Co., Ltd. (KOSDAQ 046890), a leading global innovator of LED technology, announced that it has achieved smart lighting design with SunLike Series natural spectrum LEDs in cooperation with Casambi Technologies Oy (“Casambi”), a leading developer of wireless lighting control systems based on Bluetooth Low Energy (BLE), and it has been adopted for the Italian designed architectural lighting brand formalighting Ltd. (“formalighting”), a global manufacturer of Italian designed architectural lighting systems and solutions for a new product line which offers motorized luminaire with smart wireless controls. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191213005009/en/ SunLike implemented in motion lamps (Photo: Business Wire) The SunLike COB LED packages have been adopted by formalighting for the new fixtures, Moto-Zero 40 Compasso and Moto-Zero 66 Zoom, in track mounted motorized spotlight range. In this sect
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom